Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Taiwanese (TAIEX) Clinical Research and Equipment Industry Analysis

UpdatedJun 10, 2026
DataAggregated Company Financials
Companies11
  • 7D-0.5%
  • 3M1.9%
  • 1Y-3.5%
  • YTDn/a

The Clinical Research and Equipment industry has been flat over the last week, but Locus Cell has lost 5.4%. As for the longer term, the industry has declined 3.5% in the last year.

Industry Valuation and Performance

Has the Taiwanese Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 10 Jun 2026NT$32.6bNT$2.7b-NT$746,869,000.0021.9x-43.6x12.3x
Fri, 08 May 2026NT$35.8bNT$2.5b-NT$764,028,000.0021.6x-46.9x14.2x
Sun, 05 Apr 2026NT$31.0bNT$2.5b-NT$750,275,000.0020.4x-41.3x12.4x
Tue, 03 Mar 2026NT$33.0bNT$2.4b-NT$692,870,000.0019.9x-47.7x13.6x
Thu, 29 Jan 2026NT$34.7bNT$2.4b-NT$689,929,000.0024.2x-50.3x14.3x
Sat, 27 Dec 2025NT$34.7bNT$2.4b-NT$670,921,000.0024.1x-51.7x14.2x
Mon, 24 Nov 2025NT$36.5bNT$2.4b-NT$670,921,000.0019.1x-54.4x14.9x
Wed, 22 Oct 2025NT$37.2bNT$2.5b-NT$870,437,000.0018.6x-42.8x15.2x
Fri, 19 Sep 2025NT$34.6bNT$2.5b-NT$870,437,000.0020x-39.8x14.1x
Sun, 17 Aug 2025NT$33.6bNT$2.5b-NT$601,905,000.0019.9x-55.9x13.6x
Tue, 15 Jul 2025NT$32.8bNT$2.5b-NT$600,003,000.0022.5x-54.6x13.3x
Thu, 12 Jun 2025NT$33.8bNT$2.5b-NT$600,003,000.0024.1x-56.3x13.7x
Sat, 10 May 2025NT$31.1bNT$2.5b-NT$540,128,000.0022.8x-57.6x12.6x
Mon, 07 Apr 2025NT$35.4bNT$2.5b-NT$536,440,000.0025.7x-66.1x14.4x
Wed, 05 Mar 2025NT$36.3bNT$2.6b-NT$854,432,000.0023.8x-42.5x14.2x
Fri, 31 Jan 2025NT$36.8bNT$2.6b-NT$854,432,000.0023.5x-43.1x14.4x
Sun, 29 Dec 2024NT$34.2bNT$2.6b-NT$854,432,000.0023.3x-40x13.3x
Tue, 26 Nov 2024NT$40.5bNT$2.6b-NT$854,432,000.0024x-47.4x15.8x
Thu, 24 Oct 2024NT$41.5bNT$2.3b-NT$836,610,000.0022.3x-49.6x18.2x
Sat, 21 Sep 2024NT$42.3bNT$2.3b-NT$836,610,000.0022.1x-50.6x18.6x
Mon, 19 Aug 2024NT$40.8bNT$2.3b-NT$836,610,000.0022.4x-48.8x18x
Wed, 17 Jul 2024NT$43.9bNT$2.1b-NT$797,765,000.0033.6x-55.1x20.6x
Fri, 14 Jun 2024NT$41.5bNT$2.1b-NT$797,765,000.0032.5x-52x19.4x
Sun, 12 May 2024NT$39.9bNT$2.1b-NT$899,673,000.0032.2x-44.3x18.7x
Tue, 09 Apr 2024NT$40.2bNT$2.1b-NT$903,875,000.0031.3x-44.5x19x
Thu, 07 Mar 2024NT$42.5bNT$2.1b-NT$611,249,000.0033.1x-69.5x20.6x
Sat, 03 Feb 2024NT$43.1bNT$2.1b-NT$610,218,000.0033.1x-70.7x20.8x
Mon, 01 Jan 2024NT$47.8bNT$2.1b-NT$610,218,000.0033.3x-78.4x23x
Wed, 29 Nov 2023NT$49.2bNT$2.1b-NT$610,218,000.0034.7x-80.6x23.7x
Fri, 27 Oct 2023NT$48.8bNT$2.2b-NT$497,769,000.0031.1x-98.1x21.9x
Sun, 24 Sep 2023NT$47.7bNT$2.2b-NT$497,769,000.0031.5x-95.8x21.4x
Tue, 22 Aug 2023NT$43.3bNT$2.2b-NT$497,769,000.0031.4x-86.9x19.4x
Thu, 20 Jul 2023NT$48.4bNT$2.5b-NT$274,767,000.0042.7x-176.3x19.8x
Sat, 17 Jun 2023NT$48.4bNT$2.5b-NT$274,767,000.0044.1x-176.2x19.7x
Price to Earnings Ratio

-176.2x


Total Market Cap: NT$48.4bTotal Earnings: -NT$274,767,000.00Total Revenue: NT$2.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Clinical Research and Equipment Industry Price to Earnings3Y Average -63x202420252026
Current Industry PE
  • Investors are pessimistic on the Taiwanese Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 16.9x is higher than the industry's current PS ratio of 12.3x.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 2.6% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Comparison

How does Taiwanese Clinical Research and Equipment compare with similar industries?

TW Market-1.98%
Healthcare2.67%
Life Sciences-0.53%
Clinical Research and Equipment-0.53%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6589 EirGenixNT$45.501.6%
+NT$211.9m		-26.4%PS12.2x
6986 HeXun BiosciencesNT$62.001.6%
+NT$46.0m		-19.7%PE25.5x
6662 BioLASCO TaiwanNT$30.003.1%
+NT$23.1m		-10.8%PE17.7x
6661 Welgene BiotechLtdNT$16.503.1%
+NT$11.7m		-18.5%PS1x
7607 DuoGenic StemCellsNT$13.900.7%
+NT$3.1m		36.3%n/a

Latest News

4133
NT$20.80
Abnova (Taiwan)
7D
-2.1%
1Y
-29.4%
6662
NT$30.00
BioLASCO Taiwan
7D
3.1%
1Y
-10.8%
6661
NT$16.50
Welgene BiotechLtd
7D
3.1%
1Y
-18.5%
6589
NT$45.50
EirGenix
7D
1.6%
1Y
-26.4%
6848
NT$19.60
RBC Bioscience
7D
0.8%
1Y
14.7%
6891
NT$48.65
Locus Cell
7D
-5.4%
1Y
126.8%
6939
NT$20.00
TFBS Bioscience
7D
-2.4%
1Y
-13.2%
6986
NT$62.00
HeXun Biosciences
7D
1.6%
1Y
-19.7%
7607
NT$13.90
DuoGenic StemCells
7D
0.7%
1Y
36.3%
7837
NT$99.20
Creative Life Science
7D
-4.2%
1Y
-19.3%